Navigation Links
Medical IT and Diagnostic Product Company Decision Diagnostics Announces Patent Enforcement Strategy for Their Smart Phone Based EMR Technology
Date:1/11/2012

LOS ANGELES, Jan. 11, 2012 /PRNewswire/ -- Decision Diagnostics Corp., formerly known as InstaCare Corp., (OTCQB:ISCR), a leading developer of revolutionary  Smart phone centric e-health care products and remote medical software applications, a leading provider of home medical supplies and point of care testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and the exclusive worldwide distributor of the Shasta Genstrip, today announced its Patent Enforcement Strategy for the upcoming and expected patent covering its revolutionary Smartphone EMR technologies MD@Hand and MD@Work.

The Company's patent, filed in February 2010, has 104 separate patent claims for unique proprietary technology developed for and the foundation of its MD@Hand and MD@Work mobile smart phone based EMR products. The company's patent application was published for comments in late September 2011, and based on discussions and a review of other parallel but unrelated patents granted in the medical field, the Company anticipates patent approval in the next several months..

Keith Berman, CFO and Secretary of Decision Diagnostics Corp. commented, "Patent enforcement has become a useful tool for the protection of proprietary technology. Oftentimes companies spend millions of dollars developing technologies only to see these developments become part of other products without the permission of the original developer."

In December 2011 the company created a patent prosecution pool valued at approximately $1.25 million. Subsequently the company engaged Michael Belcher, Esq. of the firm Hunter Molloy & Salcido to manage the patent prosecution pool and to hire expert firms on an as-needed basis to prosecute patent infringement claims in the U.S. and Canada. It is the Board's opinion that the Company should also benefit from the June 2010 Supreme Court ruling on Bilski v. Kappos. 

http://en.wikipedia.org/wiki/Bilski_v._Kappos

Mr. Berman concluded, "With all of the interest in mobile medical software products, the evolution and power of smart phones and the immediacy of medical data required by physicians, our MD@Hand and MD@Work products require a strong, strategic patent enforcement plan. We believe our strategy will add great value to our technologies and create potential royalty streams." 

For more information about Decision Diagnostics Corp. and its revolutionary MD@Hand cell phone centric technologies, and, Pharma Tech Solutions, Inc. and its Shasta Genstrip, please visit the Decision Diagnostics web site www.decisiondiagnostics.com or the Pharma Tech web site www.pharmatechdirect.com, or call the company at (805) 446-2973.

Forward-Looking Statements
This news release contains forward-looking statements about our business, or financial condition and prospects that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions.


'/>"/>
SOURCE Decision Diagnostics Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... to the Centers for Disease Control and Prevention (CDC), influenza vaccination ... is helping communities across Massachusetts , Connecticut ... flu shots through the end of the month. *Some exclusions ... ... shot is by the end of October, according to the Centers for ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, ... relay – Miles by Moonlight to raise money for the American Heart Association Heart ... , Teams will work together to keep their treadmills moving for 5 hours. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical ... to physician colleagues, skilled nursing facility medical directors and other clinicians at various ... Wound Care." , "At many of these conferences we get to educate other ...
Breaking Medicine News(10 mins):